EurekAlert!, a service of AAAS
Home About us
Advanced Search
30-Sep-2014 18:09
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

News By Subject

Medicine & Health


Search this subject:

 
Key: Meeting Journal Funder
Public Release: 30-Sep-2014
Annals of Neurology
Researchers show EEG's potential to reveal depolarizations following TBI
The potential for doctors to measure damaging 'brain tsunamis' in injured patients without opening the skull has moved a step closer to reality, thanks to pioneering research at the University of Cincinnati Neuroscience Institute.
Mayfield Education and Research Foundation, US Army's Psychological Health and Traumatic Brain Injury Research Program

Contact: Cindy Starr
513-558-3505
University of Cincinnati Academic Health Center

Public Release: 30-Sep-2014
2014 IEEE International Ultrasonics Symposium
'Virtual breast' could improve cancer detection
Scientists have developed a 'virtual breast' to help train clinicians in the use of ultrasound elastography. The advanced imaging technique holds promise for improving cancer detection, but only if the results are interpreted properly.
National Cancer Institute

Contact: Jennifer Donovan
jbdonova@mtu.edu
906-487-4521
Michigan Technological University

Public Release: 30-Sep-2014
Intellectual and Developmental Disabilities
New diagnostic approach for autism in Tanzania
Researchers at Brown University and the University of Georgia have developed and tested an approach for diagnosing autism in Tanzania, where such clinical assessment and intervention services are rare. The assessment battery combines several existing but culturally adapted techniques into a protocol that the researchers tested with 41 children at two Tanzanian sites.
Brown University, National Institutes of Health

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 30-Sep-2014
Journal of Allergy and Clinical Immunology
Comprehensive Study of allergic deaths in US finds medications are main culprit
Medications are the leading cause of allergy-related sudden deaths in the US, according to an analysis conducted by researchers at Montefiore Medical Center and Albert Einstein College of Medicine . The study, published online today in the Journal of Allergy and Clinical Immunology, also found that the risk of fatal drug-induced allergic reactions was particularly high among older people and African-Americans and that such deaths increased significantly in the US in recent years.
National Institutes of Health

Contact: Kim Newman
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine

Public Release: 30-Sep-2014
Nature Immunology
UCI study uncovers important process for immune system development
Research by UC Irvine immunologists reveals new information about how our immune system functions, shedding light on a vital process that determines how the body's ability to fight infection develops.
NIH/National Institute of Allergy & Infectious Diseases, NIH/National Heart, Lung & Blood Institute

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine

Public Release: 30-Sep-2014
Medical Care
Medicaid and Uninsured patients obtain new patient appointments most easily at FQHCs
Federally Qualified Health Centers granted new patient appointments to Medicaid beneficiaries and uninsured patients at higher rates than other primary care practices, in addition to charging less for visits, according to results of a new 10-state University of Pennsylvania study published this month in Medical Care.
Robert Wood Johnson Foundation

Contact: Anna Duerr
anna.duerr@uphs.upenn.edu
215-349-8369
University of Pennsylvania School of Medicine

Public Release: 30-Sep-2014
Thyroid
New guidelines for treatment of hypothyroidism endorse current therapy
Levothyroxine is considered the gold standard therapy for an underactive thyroid gland, and a new review of therapies for the condition -- including combining levothyroxine with another agent -- has not altered that assessment, say a team of investigators.Their analysis, published as a set of guidelines in the journal Thyroid (available free online), finds insufficient consistent data exist to recommend a change in use of levothyroxine -- whether generic, or sold under various trade names, such as Synthroid -- as the only drug needed to treat hypothyroidism.
National Institutes of Health

Contact: Karen Teber
km463@georgetown.edu
Georgetown University Medical Center

Public Release: 30-Sep-2014
US military making progress reducing stigma tied to seeking help for mental illness
The US Department of Defense has made progress in reducing the stigma associated with seeking help for mental illnesses such as depression and post-traumatic stress disorder, but more improvement is still needed.

Contact: Lisa Sodders
media@rand.org
310-451-6913
RAND Corporation

Public Release: 30-Sep-2014
Genes and Development
Disease decoded: Gene mutation may lead to development of new cancer drugs
The discovery of a gene mutation that causes a rare premature aging disease could lead to the development of drugs that block the rapid, unstoppable cell division that makes cancer so deadly

Contact: Laura Bailey
baileylm@umich.edu
734-647-1848
University of Michigan

Public Release: 30-Sep-2014
Integrative Biology
High-speed drug screen
Massachusetts Institute of Technology engineers have devised a way to rapidly test hundreds of different drug-delivery vehicles in living animals, making it easier to discover promising new ways to deliver a class of drugs called biologics, which includes antibodies, peptides, RNA, and DNA, to human patients.
National Institutes of Health, Packard Award in Science and Engineering, Sanofi Pharmaceuticals, Foxconn Technology Group, Hertz Foundation

Contact: Sarah McDonnell
s_mcd@mit.edu
617-253-8923
Massachusetts Institute of Technology

Public Release: 30-Sep-2014
Thyroid
New hypothyroidism treatment guidelines from American Thyroid Association
Levothyroxine (L-T4), long the standard of care for treating hypothyroidism, is effective in most patients, but some individuals do not regain optimal health on L-T4 monotherapy. An expert task force of the American Thyroid Association on thyroid hormone replacement reviewed the latest studies on L-T4 therapy and on alternative treatments to determine whether a change to the current standard of care is appropriate, and they present their recommendations in an article published in Thyroid.

Contact: Kathryn Ryan
kryan@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 30-Sep-2014
Dermatology and Therapy
Antioxidant found in grapes uncorks new targets for acne treatment
UCLA researchers have demonstrated how resveratrol, an antioxidant derived from grapes and found in wine, works to inhibit growth of the bacteria that causes acne. The team also found that combining resveratrol with a common acne medication, benzoyl peroxide, may enhance the drug's ability to kill the bacteria and could translate into new treatments.
Women's Dermatologic Society, National Institutes of Health

Contact: Rachel Champeau
rchampeau@mednet.ucla.edu
310-794-2270
University of California - Los Angeles Health Sciences

Public Release: 30-Sep-2014
Stress
How to predict who will suffer the most from stress
New research from Concordia University has found a way to identify those most susceptible to stress. That's a huge help for health-care professionals working to stop stress before it gets out of control.

Contact: Clea Desjardins
clea.desjardins@concordia.ca
514-848-2424 x5068
Concordia University

Public Release: 30-Sep-2014
New England Journal of Medicine
NEJM: Crizotinib effective in Phase 1 trial against ROS1 lung cancer
In this multi-center study of 50 patients with advanced non-small cell lung cancer testing positive for ROS1 gene rearrangement, the response rate was 72 percent, with 3 complete responses and 33 partial responses. Median progression-free survival was 19.2 months.
NIH/National Cancer Institute

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver

Public Release: 30-Sep-2014
Environmental Health
Contaminated water linked to pregnancy complications, BU study finds
Prenatal exposure to tetrachloroethylene in drinking water may increase the risk of stillbirth and placental abruption, according to a new study led by a Boston University School of Public Health researcher.

Contact: Lisa Chedekel
chedekel@bu.edu
617-571-6370
Boston University Medical Center

Public Release: 30-Sep-2014
Longitudinal report shows challenging reality of ageing with an intellectual disability
A new report launched today by the Intellectual Disability Supplement to The Irish Longitudinal Study on Ageing conducted by academics from the School of Nursing and Midwifery, Trinity College Dublin, Ireland, has highlighted the serious, complex and unique health and social challenges facing Ireland's intellectual disability population.
Health Research Board Ireland, Department of Health Ireland

Contact: Yolanda Kennedy
yokenned@tcd.ie
353-189-63551
Trinity College Dublin

Public Release: 30-Sep-2014
Journal of General Internal Medicine
Americans undergo colonoscopies too often, study finds
Colonoscopies are a very valuable procedure by which to screen for the presence of colorectal cancer. However, it seems that healthy Americans who do undergo this sometimes uncomfortable examination often have repeat screenings long before they actually should. Gina Kruse of Massachusetts General Hospital in the US and colleagues advise that endoscopists stick to the national guidelines more closely. Their findings appear in the Journal of General Internal Medicine, published by Springer.
National Cancer Institute, Health Resources and Services Administration, Ryoichi Sasakawa Fellowship Fund

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer

Public Release: 30-Sep-2014
Proceedings of the Royal Society B: Biological Sciences
In stickleback fish, dads influence offspring behavior and gene expression
Researchers report that some stickleback fish fathers can have long-term effects on the behavior of their offspring: The most attentive fish dads cause their offspring to behave in a way that makes them less susceptible to predators. These behavioral changes are accompanied by changes in gene expression, the researchers report.

Contact: Diana Yates
diya@illinois.edu
217-333-5802
University of Illinois at Urbana-Champaign

Public Release: 30-Sep-2014
Nano Letters
A heartbeat away? Hybrid 'patch' could replace transplants
Because heart cells cannot multiply and cardiac muscles contain few stem cells, heart tissue is unable to repair itself after a heart attack. Now Tel Aviv University researchers are literally setting a new gold standard in cardiac tissue engineering, using gold particles to increase the conductivity of biomaterials.

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University

Public Release: 30-Sep-2014
International Society for Microbial Ecology Journal
Virginia Tech researchers discover potential biomarker to detect 'bubble boy' disorder
A genetic disease called SCID forces patients to breathe filtered air and avoid human contact because their bodies cannot fight germs. Now, using a mouse model, Virginia Tech researchers describe a potential biomarker to detect SCID.

Contact: Sherrie Whaley
srwhaley@vt.edu
540-231-7911
Virginia Tech

Public Release: 30-Sep-2014
Health Technology Assessment
Genetic test for cancer patients could be cost-effective and prevent further cases
Screening for a genetic condition in younger people who are diagnosed with bowel cancer would be cost-effective for the British National Health Service and prevent new cases in them and their relatives, new research has concluded.
National Institute for Health UK

Contact: Louise Vennells
l.vennells@exeter.ac.uk
0044-139-272-2062
University of Exeter

Public Release: 30-Sep-2014
FASEB Journal
Synthetic sperm protein raises the chance for successful in vitro fertilization
Having trouble getting pregnant -- even with in vitro fertilization? Here's some hope: A new research report published in Oct. 2014 issue of the FASEB Journal, explains how scientists developed a synthetic version of a sperm-originated protein which induced embryo development in human and mouse eggs similar to the natural triggering of embryo development by the sperm cell during fertilization.

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology

Public Release: 30-Sep-2014
FASEB Journal
New blood test determines whether you have or are likely to get cancer
A new research report published in the Oct. 2014 issue of The FASEB Journal may make early detection and the risk assessment of cancer as easy as a simple blood test.

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology

Public Release: 30-Sep-2014
FASEB Journal
Scientists identify which genes are active in muscles of men and women
If you want your doctor to know what goes wrong with your muscles because of age, disease or injury, it's a good idea to know what 'normal' actually is. That's where a new research report published in the October 2014 issue of the FASEB Journal comes in.

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology

Public Release: 30-Sep-2014
Angewandte Chemie International Edition
Cancer therapy: Driving cancer cells to suicide
Researchers of Ludwig-Maximilians-Universitaet in Munich report that a new class of chemical compounds makes cancer cells more sensitive to chemotherapeutic drugs. They have also pinpointed the relevant target enzyme, thus identifying a new target for anti-tumor agents.

Contact: Luise Dirscherl
presse@lmu.de
49-982-180-3423
Ludwig-Maximilians-Universität München